Outpatient Rhythm Monitoring After TAVR Could Save Us from Some Pacemakers?

Delayed high-grade block after transcatheter aortic valve replacement (TAVR) goes unnoticed in patients undergoing TAVR without prior conduction disorders because, most times, it takes place during hospitalization or immediately after the procedure.

tavi vs cirugia partner i

Right bundle branch block is a risk factor, but it has poor sensitivity for the prediction of high-grade blocks, and there may be other risk factors currently unclear.

Outpatient monitoring may identify it quickly, allowing us to be expeditious regarding the implantation of a permanent pacemaker in about 10% of patients after TAVR. Further studies are obviously necessary to clarify the incidence and risk factors for proper selection of patients warranting outpatient monitoring.

This work included 150 consecutive patients who underwent TAVR between 2016 and 2018, and who did not require a pacemaker before discharge. All of them were subjected to 30-day outpatient monitoring for the detection of high-grade conduction disorders (beyond 2 days after implantation).


Read also: Mortality and Paclitaxel Devices, Data Are Aligning.


During this period, outpatient monitoring detected high-grade conduction disorders in 10% of patients, at a median of 6 days (range 3 to 24 days) after TAVR. Patients who experienced high-grade block were more likely to have hypertension and complete right bundle branch block compared with those who did not experience it.

Sensitivity and specificity of complete right bundle branch block for the prediction of delayed high-grade conduction disorders after TAVR were 27% and 94%, respectively.

Original Title: Ambulatory Rhythm Monitoring to Detect Late High-Grade Atrioventricular Block Following Transcatheter Aortic Valve Replacement.

Reference: Karen Ream et al. J Am Coll Cardiol 2019;73:2538–47.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Valve-in-Valve in Small Surgical Aortic Bioprostheses: Balloon-Expandable or Self-Expanding? Three-Year Results from the LYTEN Trial

Dysfunction of small surgical aortic bioprostheses represents a challenging scenario for transcatheter aortic valve replacement in the valve-in-valve setting, due to the higher incidence...

Can TAVI Be Safely Performed in Patients With Bicuspid Aortic Valve?

Bicuspid aortic valve (BAV) represents an anatomical challenge for transcatheter aortic valve replacement (TAVR) due to the frequent presence of elliptical annuli, fibroc calcific...

Transcatheter Paravalvular Leak Closure: Mid-Term Outcomes and Prognostic Factors

Paravalvular leaks (PVL) are a frequent complication following surgical valve replacement, occurring in 5% to 18% of prosthetic valves. Incidence varies according to valve...

After a Major Bleeding Event in Atrial Fibrillation: When Should Left Atrial Appendage Closure Be Considered?

Atrial fibrillation (AF) in patients who experience a major bleeding event represents a complex clinical scenario in which percutaneous left atrial appendage closure (LAAC)...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Valve-in-Valve in Small Surgical Aortic Bioprostheses: Balloon-Expandable or Self-Expanding? Three-Year Results from the LYTEN Trial

Dysfunction of small surgical aortic bioprostheses represents a challenging scenario for transcatheter aortic valve replacement in the valve-in-valve setting, due to the higher incidence...

AHA/ACC Guideline on the Management of Acute Pulmonary Embolism 2026

The 2026 ACC/AHA guideline for the management of acute pulmonary embolism (PE) introduces a conceptual shift by replacing the traditional “risk-based” classification with an...

How real are the adverse effects of statins? Evidence from randomized clinical trials

The safety of statins continues to be a subject of debate, partly due to the extensive list of adverse effects included in prescribing information,...